FDA — authorised 24 August 2000
- Application: NDA021077
- Marketing authorisation holder: GLAXO GRP LTD
- Status: supplemented
FDA authorised Advair Diskus on 24 August 2000
Yes. FDA authorised it on 24 August 2000.
GLAXO GRP LTD holds the US marketing authorisation.